Qinli Sun

8PUBLICATIONS
70CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Biologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 12, 2026
Facile induction of immune tolerance by an interleukin-2-TGFβ surrogate agonist.

Qinli Sun, Alison K Barrett, Masato Ogishi

|Feb 19, 2026
Rewiring STAT signaling from the cell surface with Trikine immunotherapeutics.

Grayson E Rodriguez, Yang Zhao, Yoko Nishiga

|Feb 09, 2026
Selective Immune Silencing by Targeted TGF-β Agonists.

Qinli Sun, Masato Ogishi, Hua Jiang

|Feb 06, 2026
Zbtb32 promotes CD8+ T cell differentiation and function in cancer.

Birui Pan, Qinli Sun, Ruifeng Li

|Nov 13, 2025
Ms4a7 expression in cDC1s determines cross-presentation and antitumor immunity.

Bowen Xie, Bowen Yuan, Xiaohong Zhao

|Oct 20, 2023
BCL6 promotes a stem-like CD8+ T cell program in cancer via antagonizing BLIMP1.

Qinli Sun, Dongli Cai, Dingfeng Liu

Pageof 2

Frequent Collaborators

5 joint publications

Bowen Xie

5 joint publications

Chen Dong

4 joint publications

Peng Wei

3 joint publications

K Christopher Garcia